These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 3068159)

  • 1. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical investigation of the effect of ketanserin: a new antihypertensive drug.
    Coto V; Oliviero U; Cocozza M; Lucariello A; Picano T; Coto F; Cacciatore L
    Drugs Exp Clin Res; 1989; 15(5):231-4. PubMed ID: 2676440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S; Alaimo G; Giordano U; Raineri A; Strano A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of ketanserin with atenolol: antihypertensive activity and effect on platelet function.
    Kirch W; Ohnhaus EE
    J Hypertens Suppl; 1986 Apr; 4(1):S67-71. PubMed ID: 2939216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
    Antonicelli R; Andreoni A; Saccomanno G; Gambini C; Paciaroni E
    Drugs Exp Clin Res; 1989; 15(11-12):577-81. PubMed ID: 2700320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study].
    Crispino M
    Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter study.
    Hannedouche T; Fillastre JP; Mimran A; de Tréglodé D; Schardt F; Rosenthal T; Grossman E; Rocco S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S107-12. PubMed ID: 2446056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and metabolic effects of ketanserin in diabetic patients with mild hypertension.
    Beretta-Piccoli C; Salvadé G; Bachmann C; Riesen W; Zuppinger K
    J Hum Hypertens; 1988 Aug; 2(2):103-10. PubMed ID: 3072419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research Group.
    Zehender M; Meinertz T; Hohnloser S; Geibel A; Hartung J; Seiler KU; Just H
    Clin Physiol Biochem; 1990; 8 Suppl 3():90-100. PubMed ID: 2132179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihypertensive efficacy of ketanserin in the elderly evaluated by ambulatory blood pressure measurement.
    McCormack PM; Cox JP; Marron J; Mee F; Atkins N; O'Brien E; O'Malley K
    J Hum Hypertens; 1990 Oct; 4(5):565-70. PubMed ID: 2283647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous ketanserin on severely hypertensive patients with double-blind crossover assessment of central side-effects.
    Jennings AA; Opie LH
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):120-4. PubMed ID: 2434787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
    Hosie J; Stott DJ; Robertson JI; Ball SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.
    Rosenthal J; Koehle W; Gruebel B; Fisher R
    J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study with ketanserin in essential hypertension: an Argentine experiment.
    Demartini A; Pezzano R; Bernardiner E; Torres J; Genta C; Scheijgrond H; Gypen L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S135-7. PubMed ID: 2446062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term antihypertensive efficacy of ketanserin plus chlorthalidone.
    Fasano ML; Soro S; Ferrara LA
    Drugs Exp Clin Res; 1989; 15(11-12):587-90. PubMed ID: 2700322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.